| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 02/10/2000 | CA2337692A1 Kdel receptor inhibitors |
| 02/10/2000 | CA2337492A1 Delta-related polypeptides |
| 02/10/2000 | CA2336536A1 Growth differentiation factor-11 |
| 02/10/2000 | CA2336490A1 Hematopoietic cell composition for use in transplantation |
| 02/10/2000 | CA2336263A1 Kvlqt1 - a long qt syndrome |
| 02/09/2000 | EP0977859A1 The neurotrophic factor nnt-1 |
| 02/09/2000 | EP0977857A1 Human c-maf compositions and methods of use thereof |
| 02/09/2000 | EP0977837A1 Transgenic expression in genital tract and sexual accessory glands |
| 02/09/2000 | EP0977778A2 Human nerve growth factor exon 1 and exon 3 promoters |
| 02/09/2000 | EP0977776A2 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2 |
| 02/09/2000 | EP0977477A2 Sample collection and drug delivery apparatus for freely-moving tethered laboratory animals |
| 02/09/2000 | EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 02/08/2000 | US6023011 Corticotropin-releasing factor overproducing transgenic mice |
| 02/08/2000 | US6023010 Transgenic non-human animals depleted in a mature lymphocytic cell-type |
| 02/08/2000 | US6022736 Nucleic acid vectors comprising DNase I hypersensitive sites |
| 02/03/2000 | WO2000005393A2 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 02/03/2000 | WO2000005344A1 METHOD FOR MAINTENANCE AND PROPAGATION OF GERMLINE STEM CELLS USING MEMBERS OF THE TGF-β FAMILY OF GROWTH FACTORS |
| 02/03/2000 | WO1999063814B1 Artificial media for rearing entomophages |
| 02/03/2000 | WO1999061628A3 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 02/03/2000 | WO1999060108A3 Transgenic animals produced by homologous sequence targeting |
| 02/03/2000 | WO1999052942A3 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
| 02/03/2000 | WO1999037143A3 Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
| 02/02/2000 | EP0975753A2 $g(b)-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 02/02/2000 | EP0975746A1 Transgenic mouse expressing human cd4 and fusin (cxcr4) |
| 02/02/2000 | EP0975651A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 02/02/2000 | EP0975354A1 Ligand/lytic peptide compositions and methods of use |
| 02/01/2000 | US6020537 Prion protein standard and method of making same |
| 02/01/2000 | US6020463 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target |
| 02/01/2000 | US6020144 These organisms have evolved a sophisticated ability to infect a host and evade their host's immune defenses. |
| 02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6020140 Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| 02/01/2000 | US6019965 Alveolar proteinosis |
| 02/01/2000 | US6019227 Extractor and separator apparatus |
| 02/01/2000 | CA2171982C Drug binding protein |
| 01/27/2000 | WO2000004190A1 Evolution of whole cells and organisms by recursive sequence recombination |
| 01/27/2000 | WO2000004186A1 Method for identifying mutants and molecules |
| 01/27/2000 | WO2000004157A2 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO1999057278A3 IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI) |
| 01/27/2000 | CA2720311A1 A method of producing cells with a desired property by recursive sequence recombination |
| 01/27/2000 | CA2337362A1 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/26/2000 | EP0974659A2 Viral nucleotide sequences |
| 01/26/2000 | EP0974651A1 Physiologically active protein originating in mammals |
| 01/26/2000 | EP0973934A1 Transgenically produced non-secreted proteins |
| 01/26/2000 | EP0973928A1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| 01/26/2000 | EP0973870A1 Methods for selecting germ-line competent cells in chicken embryos, and the use of the cells in the production of chimeras |
| 01/26/2000 | EP0973800A1 Novel receptor |
| 01/26/2000 | EP0973381A2 Animal model for evaluation of vaccines |
| 01/26/2000 | EP0973380A1 Model for chronic cerebral inflammation by intracerebral injection of polynucleotide |
| 01/26/2000 | EP0799305A4 Transgenic animal lacking native amyloid precursor protein |
| 01/26/2000 | CN1048731C Polynucleotide of drug binding protein as coded CSAID |
| 01/25/2000 | US6018097 Transgenic mice expressing human insulin |
| 01/25/2000 | US6018096 Animal model for engraftment, proliferation and differentiation of human hematopoietic stem cells |
| 01/25/2000 | US6018039 A recombinant nucleotide sequence with an exogenous gene coding region is inserted at a targeted position; for producing transgenic animals for the expression of a desired substance in the mammary gland or tissue of an animal |
| 01/25/2000 | US6018025 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd528 as a target |
| 01/25/2000 | US6017727 Syndecan enhancer element and syndecan stimulation of cellular differentiation |
| 01/25/2000 | US6017714 Netrins |
| 01/20/2000 | WO2000003248A1 Method for identifying a presenilinase inhibitor |
| 01/20/2000 | WO2000003019A1 Conditional mutants of influenza virus m2 protein |
| 01/20/2000 | WO2000003016A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | WO2000002997A2 Transgenic mouse expressing green fluorescent protein in astrocytes |
| 01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/20/2000 | WO2000002897A2 Delta cleavage products and methods based thereon |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002584A2 Cancer treatment methods using antibodies to aminophospholipids |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | CA2335090A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | CA2333893A1 Delta cleavage products and methods based thereon |
| 01/20/2000 | CA2333891A1 Conditional mutants of influenza virus m2 protein |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/20/2000 | CA2332344A1 Method for identifying a presenilinase inhibitor |
| 01/19/2000 | EP0972829A1 Knockout animals |
| 01/19/2000 | EP0972445A1 Pluripotent cells having disrupted intrinsic genes |
| 01/19/2000 | EP0972036A2 Prion propagation inhibition by dominant-negative prion protein mutants |
| 01/19/2000 | EP0972031A1 Procollagen assembly |
| 01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 01/19/2000 | EP0972024A1 A tumor suppressor designated ts10q23.3 |
| 01/19/2000 | EP0972018A1 Non human transgenic animal in which the expression of the gene coding for insulin is deleted |
| 01/19/2000 | EP0972017A1 Efficient nuclear transfer using fetal fibroblasts |
| 01/19/2000 | EP0972013A1 Tissue specific promoters |
| 01/19/2000 | EP0972012A1 Immunosuppression |
| 01/19/2000 | EP0971957A1 Polypeptide with appetite regulating activity |
| 01/19/2000 | EP0971724A1 Expression of active human factor ix in mammary tissue of transgenic animals |
| 01/19/2000 | EP0971603A1 Artificial media for rearing entomophages |
| 01/19/2000 | CN2358678Y Bag-type bee-escape for trichogramma |
| 01/19/2000 | CN1242046A Mammalian cytokine related to IL10 |
| 01/18/2000 | US6015938 Osteoprotegerin |
| 01/18/2000 | US6015713 Transgenic fish and a method of harvesting islet cells therefrom |
| 01/18/2000 | US6015687 Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereof |
| 01/18/2000 | CA2055494C Method to preselect the sex of offspring |
| 01/13/2000 | WO2000001846A2 Characterisation of gene function using double stranded rna inhibition |
| 01/13/2000 | WO2000001805A1 Cells and animals deficient in protein kinase c epsilon |
| 01/13/2000 | CA2789083A1 Characterisation of gene function using double stranded rna inhibition |
| 01/12/2000 | EP0971033A2 Test and model for Alzheimer's disease |
| 01/12/2000 | EP0970216A1 TRANSGENIC MICE EXPRESSING THE $i(H/K-RAS 4B) CHIMERIC GENE |
| 01/12/2000 | EP0969717A1 Photoperiodic control of growth |
| 01/12/2000 | EP0969716A1 Endometriosis mouse model |
| 01/12/2000 | CN2357501Y Silkworm net |